✦ LIBER ✦

Possible pathway for formation of fibrin degradation products during ancrod therapy

✍ Scribed by MCKILLOP, CAROLINE; EDGAR, W.; FORBES, C. D.; PRENTICE, C. R. M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The fibrinolytic response to ancrod ther

✍ C. R. M. Prentice; K. K. Hampton; P. J. Grant; S. R. Nelson; W. Nieuwenhuizen; P 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

In vivo production of soluble complexes

✍ Caroline McKillop; W. Edgar; C.D. Forbes; C.R.M. Prentice 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 824 KB

Pharmacokinetics of degradation products

✍ P. Tanswell; W. Nieuwenhuizen; E. Seifried 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 773 KB

Evolution of plasma specific fibrin degr

✍ René Faivre; Manouchehr Mirshahi; Dominique Ducellier; Claudine Soria; Jeannette 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 538 KB

Fibrin degradation products in post mort

✍ Körschenhausen, Dirk A.; Hampel, Harald J.; Ackenheil, Manfred; Penning, Randolf 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 768 KB

Characteristic effects of methylglyoxal

✍ Kenji Koizumi; Masaaki Nakayama; Wan-Jun Zhu; Sadayoshi Ito 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 399 KB